1 follower
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies
Immunome
2 followers
Elicio Therapeutics
1 follower
Nunzio Marc DeSantis Architects
1 follower
Artiva Biotherapeutics
1 follower
Lucid Management and Capital Partners LP
1 follower
Amgen
208 followers
Capricor Therapeutics
1 follower
Merkle
64 followers
Medidata Solutions
25 followers
FS
16 followers
Cytokinetics
11 followers
Explore companies